Although the advancement of maternal age is not an indicator for CS, it is associated with weakening of the myometrium, reduction in the number of oxytocin receptors, the lower clinical threshold for obstetric interventions, and increased rates of maternal systemic diseases and obstetric complications, all of which contribute to an increased risk of CS [43]. This evidence concerns the gene OXTR and Cowden syndrome 1.